Cargando…

Drug Selection and Information: Some Recommendations from the World Health Organization

Detalles Bibliográficos
Autor principal:	Herxheimer, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Royal College of Physicians of London 1993
Materias:	European Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396693/ https://www.ncbi.nlm.nih.gov/pubmed/8289157

Ejemplares similares

Implementation of Best Practice Recommendations for Palliative Care in German Comprehensive Cancer Centers
por: Gahr, Susanne, et al.
Publicado: (2019)

Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis
por: Draeger, Teresa, et al.
Publicado: (2022)

Real‐World Clinical Outcomes in Biological Subgroups of Breast Cancer in the Hospital District of Southwest Finland
por: Teerenhovi, Heli, et al.
Publicado: (2021)

Original Manufacturers' Packs and Patient Information Leaflets— A Patient's Protection and Right to Know
por: Griffin, J. P.
Publicado: (1991)

Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
por: Pasello, Giulia, et al.
Publicado: (2022)

Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with Cancer
por: Quarello, Paola, et al.
Publicado: (2023)

Health in the Czech Republic
por: Drobniewski, Francis
Publicado: (1992)

Choices in Health Care: A Review of a Report by the Government Committee on Choices in Health Care. Ministry of Welfare, Health and Cultural Affairs, the Netherlands, 1992
por: Holland, Walter W.
Publicado: (1992)

Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals
por: Fasola, Gianpiero, et al.
Publicado: (2023)

Mediators of Inflammation in Response to Air Pollution: A Focus on Ozone and Nitrogen Dioxide: A 'Concerted Action' Project in the EU Biomed2 Programme for Promoting Research That Meets the Public Health Needs of European Citizens
por: Krishna, M T, et al.
Publicado: (1996)

Growth in Prescription Medicines Expenditure: A European Comparison
por: Griffin, J. P., et al.
Publicado: (1993)

Common Trunk Medicine in the EC
por: Bouloux, Pierre-Marc Gilles
Publicado: (1993)

Safety of Medicines in Europe
por: Griffin, J P
Publicado: (1993)

Will the British Committee on Safety of Medicines Be Obsolete in 1993?
por: Griffin, J. P.
Publicado: (1991)

Czechoslovakia Revisited
por: Suri, Y. P.
Publicado: (1991)

Scandinavian Rheumatology 1990
por: Bradlow, Anthony
Publicado: (1991)

Who Will Fund the Postgraduate Education after 1992?
por: Griffin, J. P.
Publicado: (1991)

The Role of the Royal College of Physicians in Europe
por: Martin, John F.
Publicado: (1991)

Good Clinical Research Practice in Europe
por: Wells, Frank O.
Publicado: (1991)

Clinical Trials—Paper Trail or Wild Goose Chase?
por: Griffin, J. P.
Publicado: (1991)

London—The European Centre of Excellence
por: Griffin, J P
Publicado: (1994)

Coronary Artery Disease in Europe: What Are the Genetic Risk Factors?
por: Galton, D J, et al.
Publicado: (1995)

The Controlling Body for European Medicines
por: Griffin, J P
Publicado: (1994)

A Visit to Germany: Report of a Medicine-Gilliland Travelling Fellowship
por: Castleden, C M
Publicado: (1994)

Euroscreen: Ethical and Philosophical Issues of Genetic Screening in Europe
por: Chadwick, Ruth, et al.
Publicado: (1996)

Generic Substitution—Another Form of Alternative Medicine
por: Griffin, J. P.
Publicado: (1992)

Animal Welfare—The European Dimension
por: Griffin, J. P.
Publicado: (1992)

Eurospeak: An Explanatory Note
Publicado: (1992)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Medical Representation in Europe
por: Lloyd, Bernard
Publicado: (1992)

COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
por: Vrdoljak, Eduard, et al.
Publicado: (2021)

The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment
por: Purshouse, Karin, et al.
Publicado: (2023)

Resilience and Wellbeing in Mental Health Workforce: Why it Matters and How to Develop it
por: Steinebach, C.
Publicado: (2022)

Resilience Factors Preventing Schizophrenia in Ultra-high Risk Patients: Lessons from Genetics
por: Chaumette, B., et al.
Publicado: (2022)

The Importance of Continuing Breastfeeding during Coronavirus Disease-2019: In Support of the World Health Organization Statement on Breastfeeding during the Pandemic
por: Williams, Julianne, et al.
Publicado: (2020)

Co-operation Between the European Communities and CERN (for information)
Publicado: (1989)

Global Emergencies in Child Health: Challenges and Solutions—Viewpoint and Recommendations from the European Paediatric Association and the International Pediatric Association
por: Thacker, Naveen, et al.
Publicado: (2022)

Should Drug Information Be an Integral Part of Health Care?
por: Hemminki, Elina, et al.
Publicado: (1996)

The NHS Drug Budget Inquiry: A Note for the Commons Health Select Committee
por: Herxheimer, Andrew
Publicado: (1994)

Childhood tuberculosis: a concern of the modern world
por: Hamzaoui, Agnes, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o08lifuo5jrd7u265i8e1fgd9k